Article
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study.
Lipids in health and disease - 1 Aug 2024
Cai Gexiang, Liu Jingjing, Cai Mengsi, Shao Lianyou
Abstract excerpt
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a respiratory disorder of obscure etiology and limited treatment options, possibly linked to dysregulation in lipid metabolism. While several observational studies suggest that lipid-lowering agents may decrease the risk of IPF, the evidence is inconsistent. The present Mendelian randomization (MR) study aims to determine the association between circulating lipid...
Topics
Join the communities discussing this publication.
